ALL CONTENT - Key Persons

Amy Gordon Franzen

Job Titles:

Member of the Leadership Team
Senior Vice President of Trials at Tempus

Amy serves as the Senior Vice President of Trials at Tempus, where she leads all internal and external trial recruitment and clinical trial support efforts. Prior to joining Tempus, Amy spent her career at the intersection of business and technology as a strategic operator at Nike and Groupon. In addition to her operating roles, she was a management consultant at Mckinsey & Company, where she advised clients across multiple industries in growth strategy and operational excellence. Amy graduated from Cornell University with a BS in Applied Economics and Management.

Andy Polovin - Chief Legal Officer

Job Titles:

General Counsel
Member of the Leadership Team
General Counsel at Tempus

Andy Polovin serves as General Counsel at Tempus, where he oversees and is responsible for various legal and business issues. Prior to joining Tempus, Andy was the General Counsel of Uptake Technologies, Inc., a company specializing in Artificial Intelligence software for heavy industry. Andy has also served as an Assistant United States Attorney focusing on narcotics and white-collar crime investigations; an equity partner at Bartlit Beck, one of the nation's leading trial boutiques; and a Law Clerk to the Chief Judge of the U.S. Court of Appeals for the Seventh Circuit. Andy graduated from Colgate University and earned his law degree from Northwestern University School of Law.

Chris Scotto - SVP

Job Titles:

General Manager
Member of the Leadership Team
Senior Vice President
Senior Vice President & General Manager of AI

Chris Scotto DiVetta serves as the Senior Vice President & General Manager of AI. Prior to Tempus, Chris worked as VP & General Manager at Quest Diagnostics where he established their Advanced Genomics and Pharma Services businesses as well as led their Neurology business unit that launched the first accessible blood based dementia diagnostic. Chris has had General Manager, Product Management, and technology leadership roles at NVIDIA and GE Healthcare focused on building smart medical devices and diagnostics by leveraging advancements in AI, data analytics, and cloud technology. Chris holds a B.S. in Computer Engineering and an MBA, from the University of Wisconsin-Madison.

Christina Antoniou

Job Titles:

Member of the Leadership Team
Senior Vice President, Head of Corporate Development at Tempus

Christina Antoniou serves as Senior Vice President, Head of Corporate Development at Tempus, where she is responsible for the company's mergers, acquisitions, partnerships and strategic investing efforts. Christina has extensive experience executing strategic and financial transactions in the healthcare industry. Before joining Tempus, Christina spent four years at Medidata Solutions, a Dassault Systèmes company. There, she held multiple roles, including Vice President, Head of Integration and Senior Director, Corporate Development. At Medidata, Christina completed several strategic acquisitions and early-stage investments. Later she represented Medidata in its sales process, culminating in the sale of Medidata to Dassault Systèmes for $5.8 billion. After the acquisition, Christina led Medidata's integration with Dassault Systèmes. Earlier in her career, Christina held roles in investment banking and venture capital. Christina received an MBA from the Wharton School and holds a BA from Smith College.

David R. Epstein

"Tempus has developed a distinct set of solutions that has real potential to revolutionize cancer care. I look forward to working with the leadership team in developing those offerings to provide even more value to the company, its partners, and ultimately patients.

Dr. Calvin Chao

Job Titles:

Senior Vice President of Medical Affairs at Tempus

Dr. Calvin Chao is the Senior Vice President of Medical Affairs at Tempus. Previously, Dr. Chao spent thirteen years leading studies and education for the Oncotype DX Breast, Prostate, and Colon Cancer assays at Genomic Health, later acquired by Exact Sciences. Prior to that role, he worked in various bio-pharmaceutical medical director positions at Onyx Pharmaceuticals, PDL BioPharma, TAP Pharmaceuticals, and SmithKline Beecham. In his early career, Dr. Chao practicedas a board-certified internist and hospitalist at Kaiser Permanente in California for ten years. He earned his MD from the University of Texas Medical Branch, completed his medical residency at Presbyterian-St. Luke's Medical Center in Denver, Colorado, received his MBA from St. Mary's College, California, and his BS in Chemical Engineering from University of California, Berkeley.

Dr. David Agus

Job Titles:

Scientific Advisor
Chairman of the Scientific Advisory Board at Tempus

Dr. David Agus is Chairman of the Scientific Advisory Board at Tempus. He is a professor of medicine and engineering at the University of Southern California, where he leads USC's Lawrence J. Ellison Institute for Transformative Medicine. He specializes in treating patients with advanced cancer. At USC, his clinical responsibilities include the development of clinical trials for new drugs and treatments for cancer, supported by the National Cancer Institute and other private foundations. He earned a bachelor's degree from Princeton University, his medical degree from University of Pennsylvania's School of Medicine, and participated in a fellowship in medical oncology at Memorial Sloan-Kettering Cancer Center.

Dr. Funmi Olopade

Job Titles:

Scientific Advisor
Scientific Advisor at Tempus

Dr. Funmi Olopade serves as Scientific Advisor at Tempus. A practicing medical oncologist, she is the Walter L Palmer Distinguished Service professor of medicine and director of the Center for Clinical Cancer Genetics at the University of Chicago Medical Center. The consummate clinician scientist, Dr. Olopade's research is focused on advancing novel strategies to prevent and treat cancer based on an understanding of the altered genetic pathways in individual patients. Dr. Olopade has received numerous honors and awards, including honorary degrees from Bowdoin, Princeton, North Central, and Dominican universities. She is also a recipient of the Doris Duke Distinguished Clinical Scientist and Exceptional Mentor Award, an American Cancer Society Clinical Research Professorship, a MacArthur Foundation Fellowship, a Franklin Roosevelt Freedom from Want Award, The Gregory Mendel Medal, and Officer of the Order of the Niger Award. Dr. Olopade is an elected member of the National Academy of Medicine, American Academy of Arts and Sciences, and the American Philosophical Society. She currently serves on the board of directors for the Susan G. Komen for the Cure, MacArthur Foundation, the Lyric Opera of Chicago, and Cancer IQ. Dr. Olopade received her bachelor's and medical degree from the University of Ibadan in her native country Nigeria.

Dr. Halla Nimeiri

Job Titles:

Chief Development Officer
Member of the Leadership Team
Chief Development Officer of Oncology at Tempus

Dr. Halla Nimeiri serves as the Chief Development Officer of Oncology at Tempus. Prior to Tempus, she held clinical development positions at Foundation Medicine and AbbVie. Dr. Nimeiri is a dedicated oncologist. She brings expertise in clinical trial design, drug development, and precision oncology. Dr. Nimeiri is an active academic clinician at Feinberg School of Medicine, where she provided transformative patient care for over 10 years. Dr. Nimeiri earned her dual fellowship in Hematology/Oncology from The University of Chicago.

Dr. Joel Dudley

Job Titles:

Chief
Scientific Advisor
Chief Scientific Advisor at Tempus

Dr. Joel Dudley serves as the Chief Scientific Advisor at Tempus. Dr. Dudley was Associate Professor of Genetics and Genomic Sciences and founding Director of the Institute for Next Generation Healthcare at the Icahn School of Medicine at Mount Sinai. He also served as Executive Vice President for Precision Health for the Mount Sinai Health System. Prior to Mount Sinai, he held positions as co-founder of NuMedii, Inc. developing machine learning technologies for drug discovery and Consulting Professor of Systems Medicine in the Department of Pediatrics at Stanford University School of Medicine. His more than 200 peer-reviewed research publications established novel precision medicine paradigms at the nexus of -omics, digital health, artificial intelligence (AI), scientific wellness, and healthcare delivery. His work has been featured in the New York Times, Wall Street Journal, Scientific American, MIT Technology Review, CNBC, and other popular media outlets. He was named in 2014 as one of the 100 most creative people in business by Fast Company magazine. He is co-author of the book Exploring Personal Genomics from Oxford University Press. Dr. Dudley received a BS in Microbiology from Arizona State University and an MS and PhD in Biomedical Informatics from Stanford University School of Medicine.

Dr. Kate Sasser

Job Titles:

Chief Scientific Officer
Member of the Leadership Team
Chief Scientific Officer of Tempus

Dr. Kate Sasser is the Chief Scientific Officer of Tempus. Dr. Sasser brings over 20 years of experience in translational research and precision medicine in biological sciences across academia and the pharmaceutical and biotech industry. Prior to Tempus, she led the translational research, precision medicine, and R&D operations organizations within Genmab, a biotech company focused on developing transformative antibody therapeutics as medicine. She also led translational research for oncology at Johnson and Johnson (Janssen PRD), using translational and data science approaches to accelerate clinical development. Dr. Sasser graduated from Oregon State University with a BS in Microbiology, and received her PhD in integrated biomedical sciences from Ohio State University.

Dr. Keith Stewart

Job Titles:

Scientific Advisor at Tempus

Dr. Keith Stewart serves as Scientific Advisor at Tempus. He is a consultant in the Division of Hematology and Oncology, at Mayo Clinic. He currently serves as the Carlson and Nelson Endowed Director of the Mayo Clinic Center for Individualized Medicine and is recognized as the Vasek and Anna Maria Polak Professor of Cancer Research. Dr. Stewart's current responsibilities at Mayo Clinic relate to the application of genomics to human health across the spectrum of discovery, translation and application to clinical practice. Dr. Stewart has served in several leadership roles across both research and clinical practice at Mayo Clinic, including as Dean for research in Arizona, and as a member of the Arizona Executive Operations Team and Clinical Practice committee. He has served on multiple boards for both non-profit and commercial organizations, including currently as a Non-Executive Board member for Genomics England and the Scientific Advisory Boards of Helix Inc., Veritas Genetics Inc., and the Multiple Myeloma Research Foundation investment fund. His own research interest is in the genomics and treatment of myeloma and he has led numerous clinical trials of new drugs for this blood cancer. Dr. Stewart and has authored over 300 journal articles, is named on 28 patents and has served as an associate editor of Blood and ASH Clinical News.

Dr. Kevin White

Job Titles:

Scientific Advisor
Scientific Advisor and Fellow at Tempus

Dr. Kevin White is a Scientific Advisor and Fellow at Tempus. He served as President and as Chief Science Officer during the company's first five years. Dr. White is a pioneer in generating and analyzing large-scale biological datasets to generate insights into complex biological systems, and since the mid 2000's, he has focused his efforts on developing new approaches for accelerating precision medicine through the analysis of large scale ‘omics and clinical data. Prior to Tempus, Dr. White was the James and Karen Frank Family Professor of Human Genetics and Medicine and Founding Director of the Institute for Genomics and Systems Biology in Chicago. His recognitions for innovation include the Keck Biomedical Investigator award, the Beckman Young Investigator award and Crain's Business ‘40 Under 40' list. He has served on the scientific boards of a wide range of start-up biotech companies and foundations. He is a founder of Provaxus, Inc. and of HealthSeq Pvt. Ltd. (now Tempus Singapore Pvt. Ltd.), and he has held scientific advisory board positions at institutions that include Harvard University, Yale University, Northwestern University, and the National Cancer Institute. He currently also holds a position as Professor of Biochemistry and Medicine at the National University of Singapore and the Genome Institute of Singapore. Dr. White has a B.S. and M.S. from Yale and a Ph.D. from Stanford University.

Dr. Kim Blackwell

Job Titles:

Chief Medical Advisor
Tempus' Chief Medical Advisor

Dr. Kim Blackwell serves as Tempus' Chief Medical Advisor. She joins Tempus from Eli Lilly, where she was Vice President of Early Phase Oncology and Immuno-oncology. Prior to that, she was a Professor of Medicine and Assistant Professor of Radiation Oncology at Duke University, where she directed the Women's Cancer Program, Strategic Collaborations, and the Precision Medicine Initiative for the Duke Cancer Institute.

Eric Belcher

Job Titles:

Chief Executive Officer, Numerator

"The next major evolution in health care will be the embrace of data to dramatically improve patient outcomes, and I believe Tempus is the company that is best positioned to lead this transition. The team at Tempus is exceptional, and as committed to the mission as can be.

Eric Lefkofsky - CEO, Founder

Job Titles:

CEO
Founder
Member of the Leadership Team
Founder and CEO at Tempus

Eric Lefkofsky is the founder and CEO at Tempus, a leading provider of technology enabled precision medicine solutions. He is a founding partner of Lightbank, a venture fund investing in disruptive technology businesses. He is also the co-founder and Chairman of Groupon (NASDAQ: GRPN), a global e-commerce marketplace, and co-founder of Mediaocean, a leading provider of integrated media procurement technology; Echo Global Logistics (NASDAQ: ECHO), a technology-enabled transportation and logistics outsourcing firm; InnerWorkings (NASDAQ: INWK). He co-chairs the Lefkofsky Family Foundation with his wife Liz to advance high-impact initiatives that enhance lives in the communities served. Lefkofsky serves as a Trustee of Lurie Children's Hospital of Chicago, The Art Institute of Chicago, The Museum of Science and Industry, and World Business Chicago. He is also Chairman of the Board of Trustees of Chicago's Steppenwolf Theatre Company. Lefkofsky is an adjunct professor at the University of Chicago and author of Accelerated Disruption: Understanding the True Speed of Innovation. He graduated from the University of Michigan and received his Juris Doctor at University of Michigan Law School. For more information, visit lefkofsky.com, connect on LinkedIn and follow him on Twitter (@lefkofsky) and Facebook (@eplefkofsky).

Eric Topol

Job Titles:

Scientific Advisor
Scientific Advisor at Tempus

Dr. Topol serves as Scientific Advisor at Tempus. He is the Executive VP and Professor of Molecular Medicine at The Scripps Research Institute (TSRI) and the Founder and Director of the Scripps Translational Science Institute (STSI). As a researcher, he has published over 1100 peer-reviewed articles. His principal scientific focus has been on the genomic and digital tools to individualize medicine-and the power that brings to individuals who are driving the future of medicine. In 2016, Dr. Topol was awarded a $207M grant from the NIH to lead a significant part of the Precision Medicine Initiative, a one million American prospective research program. Prior to coming to lead STSI in 2007, where he is the principal investigator of a flagship $33M NIH grant, he led the Cleveland Clinic to become the #1 center for heart care and was the founder of a new medical school there. He has been voted as the #1 most influential physician leader in the United States in a national poll conducted by Modern Healthcare. Dr. Topol received his bachelor's degree in biomedicine from the University of Virginia, Charlottesville, and his medical degree from the University of Rochester.

Erik Phelps - EVP

Job Titles:

Chief
Executive Vice President
Member of the Leadership Team
EVP and Chief Administrative and Legal Officer
Legal Officer

Erik Phelps serves as Executive Vice President and Chief Administrative and Legal Officer at Tempus. He oversees various functions within the company, including legal, quality, compliance, corporate risk, and external affairs in addition to working closely with communications and human resources. Prior to joining Tempus, he was the General Counsel at Epic, a software company that provides electronic health records for medical groups, hospitals and healthcare organizations. Prior to his time there, he served as a partner at Michael Best & Friedrich LLP in Madison, WI where he focused on software licensing and technology-related work, including work with early-stage companies. He earned a bachelor's degree from Beloit College and his J.D. from George Washington University Law School.

Ezra Cohen

Job Titles:

Member of the Leadership Team
Chief Medical Officer of Oncology

Dr. Cohen is a leading medical oncologist and cancer researcher who brings a unique combination of extensive clinical and research experience to Tempus' leadership team. He was most recently the Chief of the Division of Hematology-Oncology as well as the Associate Director of Clinical Science at UC San Diego (UCSD) Moores Cancer Center. Dr. Cohen also led the Precision Immunotherapy Clinic and co-directed the San Diego Center for Precision Immunotherapy at UCSD. Before UCSD, Dr. Cohen spent 15 years at the University of Chicago, where he was the co-director of the Head and Neck Cancer Program as well as Hematology/Oncology Fellowship Program Director.

Greg Fisbeck

Job Titles:

Chief Information Security Officer
Member of the Leadership Team
Tempus' Chief Information Security Officer

Greg is Tempus' Chief Information Security Officer, responsible for leading the Information Security team, managing information security risks, and protecting data integrity and privacy. Prior to joining Tempus, Greg led the Global Security Operations team at the Whirlpool Corporation, a leading manufacturer of home appliances. Greg earned his Bachelor of Science in Information Technology from Colorado State University.

Iker Huerga - EVP

Job Titles:

Executive Vice President
Member of the Leadership Team
EVP, Life Science Strategy and Real World Data

Iker Huerga is the Executive Vice President, Life Science Strategy and Real World Data at Tempus. Iker brings more than 15 years of experience in Oncology Drug Development, Data Science and Technology. Prior to joining Tempus, Iker was the Chief Data Scientist for Oncology R&D at AstraZeneca where his organization was responsible for all analyses from early discovery to registration; with a particular emphasis on P1-Ph3 clinical trial design. Before that, he was the Scientific Director of Engineering and Applied Machine Learning at Memorial Sloan Kettering Cancer Center under the mentorship of José Baselga. Iker has also founded three startups in the precision oncology space with two successful exits.

Jim Rogers - CFO

Job Titles:

Chief Financial Officer
Member of the Leadership Team
Chief Financial Officer at Tempus

Jim Rogers serves as Chief Financial Officer at Tempus, where he is responsible for overseeing the Company's Accounting, FP&A, Treasury, and Investor Relations' functions. Prior to joining Tempus, Jim held various finance positions at Groupon, including leading FP&A for the North America business and serving as the financial controller of Asia Pacific operations. Prior to Groupon, Jim was part of Ernst & Young's assurance practice, where he worked with various financial services firms. Jim earned his B.B.A. in Accounting from the University of Notre Dame and his MS in Accounting from Northern Illinois University.

Kimberly Yeatts

Job Titles:

Member of the Leadership Team
Vice President of Clinical Lab Operations at Tempus

Kimberly Yeatts serves as the Vice President of Clinical Lab Operations at Tempus. Prior to joining Tempus, Yeatts worked as the Director of Molecular Assay Development at Med Fusion. Earlier, she worked at Caris Life Sciences where she served in a number of different roles and was responsible for everything from next generation sequencing assay development to molecular diagnostic lab management to emerging technology scientific assessments. Yeatts earned her Bachelor of Science in Biology from Arizona State University and completed post baccalaureate training at the National Institutes of Health.

Laura Elster - SVP

Job Titles:

Member of the Leadership Team
Senior Vice President
Senior Vice President of Provider Sales

Laura Elster serves as Senior Vice President of Provider Sales, leading our sales teams to deliver AI-enabled precision medicine solutions to health systems and patients across clinical specialties. Prior to joining Tempus, Laura spent more than 13 years with St. Jude Medical, Inc. providing clinical services and collaborating with clinical teams to improve patient outcomes in Cardiac Electrophysiology. Laura holds a Bachelor of Science in Biomedical Engineering from Washington University in St. Louis.

Lauren Silvis

Job Titles:

Member of the Leadership Team
Senior Vice President of External Affairs at Tempus

Lauren Silvis serves as Senior Vice President of External Affairs at Tempus, overseeing regulatory, public policy, government affairs and strategic communications. She has held a number of senior career public health roles, serving as a Senior Advisor at the Department of Health and Human Services, Chief of Staff of the Food and Drug Administration and Deputy Center Director for Policy in FDA's Center for Devices and Radiological Health. She currently serves as a member of the Council of Councils for the National Institutes of Health. During her time in government, she advanced policies to promote innovation in precision medicine, real world evidence, clinical trials and digital health. Lauren serves as Board Vice Chair for the Personalized Medicine Coalition and a board member for the Real-World Evidence Alliance. Earlier in her career, she was a partner at the international law firm Sidley Austin LLP, focusing on regulation of pharmaceuticals and medical devices. Lauren graduated from Duke University and earned her law degree from Georgetown University Law Center.

Lee Black

Job Titles:

Member of the Leadership Team
Senior Vice President & General Manager of Real World Data

Lee Black serves as the Senior Vice President & General Manager of Real World Data. He is responsible for Tempus's multimodal, de-identified, Real World Data products, which includes Lens software-as-a-service. Prior to Tempus, Lee worked at Amazon Web Services (AWS) where he held multiple sales leadership roles in Global Life Sciences and established the Genomics business unit focused on precision medicine. Prior to AWS, Lee was VP of Sales for Comprehend Systems, a leader in cloud based clinical trial optimization software. Lee graduated from Virginia Tech with a BS in Computer Science and Mathematics.

Marc Yoskowitz

Job Titles:

EVP and Chief Strategy Officer, Life Sciences

Marc Yoskowitz serves as EVP and Chief Strategy Officer, Life Sciences at Tempus. Prior to Tempus, Yoskowitz was Chief Business Officer, Pfizer Essential Health, leading a range of corporate initiatives and businesses within the Pfizer portfolio. Prior to Pfizer, he served as SVP, Strategy and Corporate Development at Hospira, where he led the company's efforts in these areas and was a member of the Executive Committee. Earlier in his career, Yoskowitz led business development at a specialty pharmaceutical company, spent eight years at McKinsey & Company where he was an Associate Principal, and began his career as an M&A lawyer at Davis, Polk & Wardwell in New York. Yoskowitz received a bachelor's degree magna cum laude from Washington University in St. Louis and holds a JD from Columbia University School of Law in New York.